Piramal Pharma Limited (PPLPHARMA) — Board Meeting | 5 June 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Piramal Pharma announced the allotment of 21 lakh equity shares to its Employee Welfare Trust under the 2022 ESOP Scheme, increasing paid-up capital from Rs. 1,329.25 crores to Rs. 1,331.35 crores. The shares, each with a face value of Rs. 10, were allotted on 5 June 2026 and will be transferred to eligible employees upon option exercise. Listing fees of Rs. 5,259.60 and Rs. 5,534.50 were paid to BSE and NSE respectively on 3 June 2026.

📄 View Original Announcement (PDF)

About Piramal Pharma Limited (PPLPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹23,244.56 Cr P/E: 582.9

View full PPLPHARMA stock details →

📡 Get AI alerts when PPLPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track PPLPHARMA — Free

📊 More PPLPHARMA filings

See all PPLPHARMA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when PPLPHARMA files new disclosures

Track PPLPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track PPLPHARMA — Free

Free account · 2 AI queries/day